AbCellera Biologics (ABCL) Tax Rate (2021 - 2026)
AbCellera Biologics' (ABCL) quarterly Tax Rate came in at 12.86% in Q1 2026, down 103.0% YoY from 428.77% in Q1 2025, and down 76.23% on a QoQ basis from 54.13% in Q4 2025.
AbCellera Biologics (ABCL) Tax Rate (2021 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 6 years of Tax Rate data on file, last reported at 12.86% in Q1 2026.
- Quarterly Tax Rate fell 103.0% year-over-year to 12.86% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 17.34% (down 297.0% YoY) and the FY2025 annual result came in at 17.56%, down 117.0% from the prior year.
- Tax Rate slipped to 12.86% in Q1 2026, from 54.13% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 54.13% in Q4 2025 to a low of 1.47% in Q2 2022.
- A 5-year average of 18.74% and a median of 16.94% in 2025 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 2847 bps in 2022, down 2440 bps in 2022.
- Tracing ABCL's Tax Rate over 5 years: stood at 4.84% in 2022, then plunged by 38 bps to 2.99% in 2023, then jumped by 802 bps to 26.95% in 2024, then soared by 101 bps to 54.13% in 2025, then slumped by 76 bps to 12.86% in 2026.
- The last three Tax Rate figures came in at 12.86% (Q1 2026), 54.13% (Q4 2025), and 16.94% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | 6.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00% |
| Jun 30, 2026 | 6.00% |
| Jun 30, 2026 | 6.00% |
| Mar 31, 2026 | 12.86% |
| Mar 31, 2026 | 12.86% |
| Mar 31, 2026 | 12.86% |
| Dec 31, 2025 | 54.13% |
| Dec 31, 2025 | 54.13% |
| Dec 31, 2025 | 54.13% |
| Sep 30, 2025 | 16.94% |
| Sep 30, 2025 | 16.94% |
| Sep 30, 2025 | 16.94% |
| Jun 30, 2025 | 4.45% |
| Jun 30, 2025 | 4.45% |
| Jun 30, 2025 | 4.45% |
| Mar 31, 2025 | 13.90% |
| Mar 31, 2025 | 13.90% |
| Mar 31, 2025 | 13.90% |
| Dec 31, 2024 | 26.95% |
| Dec 31, 2024 | 26.95% |